MSB 3.88% $1.07 mesoblast limited

Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-52

  1. 205 Posts.
    lightbulb Created with Sketch. 105
    Give them a break, it’s obvious that there is still a fair way to go. Just say congratulations and watch from the sideline, surely MSB holders deserve to enjoy a win.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.